Cargando…
Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712691/ https://www.ncbi.nlm.nih.gov/pubmed/33047915 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0713.1 |
_version_ | 1783618426606977024 |
---|---|
author | dos Reis, Rodolfo Borges Muglia, Valdair Francisco Rodrigues, Antônio Antunes Viani, Gustavo |
author_facet | dos Reis, Rodolfo Borges Muglia, Valdair Francisco Rodrigues, Antônio Antunes Viani, Gustavo |
author_sort | dos Reis, Rodolfo Borges |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7712691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Sociedade Brasileira de Urologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-77126912020-12-05 Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes dos Reis, Rodolfo Borges Muglia, Valdair Francisco Rodrigues, Antônio Antunes Viani, Gustavo Int Braz J Urol Editorial Comment Sociedade Brasileira de Urologia 2020-11-18 /pmc/articles/PMC7712691/ /pubmed/33047915 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0713.1 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Comment dos Reis, Rodolfo Borges Muglia, Valdair Francisco Rodrigues, Antônio Antunes Viani, Gustavo Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
title | Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
title_full | Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
title_fullStr | Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
title_full_unstemmed | Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
title_short | Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
title_sort | editorial comment: endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes |
topic | Editorial Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712691/ https://www.ncbi.nlm.nih.gov/pubmed/33047915 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0713.1 |
work_keys_str_mv | AT dosreisrodolfoborges editorialcommentendoclipsasnovelfiducialmarkersintrimodalitybladderpreservingtherapyofmuscleinvasivebladdercarcinomafeasibilityandpatientoutcomes AT mugliavaldairfrancisco editorialcommentendoclipsasnovelfiducialmarkersintrimodalitybladderpreservingtherapyofmuscleinvasivebladdercarcinomafeasibilityandpatientoutcomes AT rodriguesantonioantunes editorialcommentendoclipsasnovelfiducialmarkersintrimodalitybladderpreservingtherapyofmuscleinvasivebladdercarcinomafeasibilityandpatientoutcomes AT vianigustavo editorialcommentendoclipsasnovelfiducialmarkersintrimodalitybladderpreservingtherapyofmuscleinvasivebladdercarcinomafeasibilityandpatientoutcomes |